Predicted Trait | |
Reported Trait | Glaucoma |
Mapped Trait(s) | glaucoma (MONDO_0005041) |
Score Construction | |
PGS Name | MTAG_glaucoma |
Development Method | |
Name | Clumping and Thresholding (C+T) |
Parameters | r2 = 0.1; p < 0.001 |
Variants | |
Original Genome Build | NR |
Number of Variants | 2,673 |
Effect Weight Type | NR |
PGS Source | |
PGS Catalog Publication (PGP) ID | PGP000066 |
Citation (link to publication) | Craig JE et al. Nat Genet (2020) |
Ancestry Distribution | |
Source of Variant Associations (GWAS) | European: 100% 351,696 individuals (100%) |
Score Development/Training | European: 100% 8,004 individuals (100%) |
PGS Evaluation |
Study Identifiers | Sample Numbers | Sample Ancestry | Cohort(s) |
---|---|---|---|
GWAS Catalog: GCST009722 Europe PMC: 31959993 |
351,696 individuals | European | NR |
Study Identifiers | Sample Numbers | Sample Ancestry | Cohort(s) | Phenotype Definitions & Methods | Age of Study Participants | Participant Follow-up Time | Additional Ancestry Description | Additional Sample/Cohort Information |
---|---|---|---|---|---|---|---|---|
— | [
|
European | ANZRAG | Advanced glaucoma | — | — | — | Used to select the optimal p-value threshold. Adjusted for sex and first four PCs |
— | [ ,
47.0 % Male samples |
European | NR | Advanced glaucoma | Mean = 59.0 years Sd = 10.16 years |
— | — | Used to replicate OR seen in ANZRAG on UK cases from Southhampton and Liverpool |
PGS Performance Metric ID (PPM) |
PGS Sample Set ID (PSS) |
Performance Source | Trait |
PGS Effect Sizes (per SD change) |
Classification Metrics | Other Metrics | Covariates Included in the Model |
PGS Performance: Other Relevant Information |
---|---|---|---|---|---|---|---|---|
PPM000422 | PSS000245| European Ancestry| 1,795 individuals |
PGP000066 | Craig JE et al. Nat Genet (2020) |
Reported Trait: Primary open-angle glaucoma (POAG) | — | AUROC: 0.8 | — | age, sex, self-reported family history | — |
PPM000426 | PSS000249| South Asian Ancestry| 7,033 individuals |
PGP000066 | Craig JE et al. Nat Genet (2020) |
Reported Trait: Glaucoma | — | AUROC: 0.76 [0.73, 0.79] | — | age, sex | Model 3 |
PPM000424 | PSS000248| European Ancestry| 3,112 individuals |
PGP000066 | Craig JE et al. Nat Genet (2020) |
Reported Trait: Glaucoma | — | AUROC: 0.75 [0.73, 0.76] | — | age, sex | Model 3 |
PPM000429 | PSS000247| European Ancestry| 3,112 individuals |
PGP000066 | Craig JE et al. Nat Genet (2020) |
Reported Trait: Primary open-angle glaucoma (POAG) | — | AUROC: 0.76 [0.72, 0.81] | — | age, sex | Model 3 |
PPM000425 | PSS000249| South Asian Ancestry| 7,033 individuals |
PGP000066 | Craig JE et al. Nat Genet (2020) |
Reported Trait: Glaucoma | — | AUROC: 0.64 [0.59, 0.68] | — | — | Model 1 |
PPM000423 | PSS000248| European Ancestry| 3,112 individuals |
PGP000066 | Craig JE et al. Nat Genet (2020) |
Reported Trait: Glaucoma | — | AUROC: 0.66 [0.64, 0.68] | — | — | Model 1 |
PPM000428 | PSS000247| European Ancestry| 3,112 individuals |
PGP000066 | Craig JE et al. Nat Genet (2020) |
Reported Trait: Primary open-angle glaucoma (POAG) | — | AUROC: 0.67 [0.63, 0.72] | — | — | Model 1 |
PPM000427 | PSS000246| European Ancestry| 965 individuals |
PGP000066 | Craig JE et al. Nat Genet (2020) |
Reported Trait: Glaucoma in MYOC p.Gln368Ter carriers | — | — | HR (Hazard Ratio; highest vs. lowest tertile of PRS): 3.4 [1.7, 6.6] | sex, PCs 1-6 | — |
PPM000421 | PSS000245| European Ancestry| 1,795 individuals |
PGP000066 | Craig JE et al. Nat Genet (2020) |
Reported Trait: Primary open-angle glaucoma (POAG) | — | AUROC: 0.71 [0.66, 0.77] | — | — | — |
PPM016165 | PSS010053| European Ancestry| 1,103 individuals |
PGP000403 | Siggs OM et al. JAMA Ophthalmol (2022) |Ext. |
Reported Trait: Visual field worsening | — | — | Hazard ratio (HR, top 5% vs bottom 95%): 1.5 [1.13, 1.97] Hazard ratio (HR, bottom 20% vs intermediate risk): 0.52 [0.28, 0.96] |
— | — |
PPM020780 | PSS011408| European Ancestry| 903 individuals |
PGP000588 | Marshall HN et al. Ophthalmol Glaucoma (2022) |Ext. |
Reported Trait: Age at first trabeculectomy in individuals with primary open-angle glaucoma | β: -1.94 [-3.47, -0.41] | — | — | Sex, family history of glaucoma | — |
PPM020781 | PSS011408| European Ancestry| 903 individuals |
PGP000588 | Marshall HN et al. Ophthalmol Glaucoma (2022) |Ext. |
Reported Trait: Requirement for bilateral trabeculectomy in individuals with primary open-angle glaucoma | — | — | Odds ratio (OR, top vs bottom PRS decile): 1.41 [1.06, 1.91] | — | — |
PPM022190 | PSS011837| Multi-ancestry (including European)| 455 individuals |
PGP000688 | Saks DG et al. Acta Ophthalmol (2023) |Ext. |
Reported Trait: Vascular wedge presence in individuals with glaucoma | — | — | p: 0.007 | Age, sex, optic disc haemorrhage | — |
PPM022191 | PSS011837| Multi-ancestry (including European)| 455 individuals |
PGP000688 | Saks DG et al. Acta Ophthalmol (2023) |Ext. |
Reported Trait: Retinal nerve fibre layer wedge presence in individuals with glaucoma | — | — | p: 0.07 | Age, sex, optic disc haemorrhage | — |
PGS Sample Set ID (PSS) |
Phenotype Definitions and Methods | Participant Follow-up Time | Sample Numbers | Age of Study Participants | Sample Ancestry | Additional Ancestry Description | Cohort(s) | Additional Sample/Cohort Information |
---|---|---|---|---|---|---|---|---|
PSS010053 | — | — | 1,103 individuals | — | European | — | PROGRESSA | Ancestrally matched normative population cohort (n = 17 642) was used for PRS reference |
PSS000245 | — | — | [ ,
43.0 % Male samples |
Mean = 64.02 years Sd = 8.24 years |
European | — | BMES | — |
PSS000246 | MYOC p.Gln368Ter (rs74315329) carriers using imputation. Glaucoma cases were defined as those who (i) had an ICD-10 diagnosis of ‘primary open angle glaucoma’, ‘other glaucoma’ or ‘glaucoma, unspecified’; (ii) responded ‘glaucoma’ to the question ‘Has a doctor told you that you have any of the following problems with your eyes?’; or (iii) responded ‘glaucoma’ to the question ‘In the touch screen you selected that you have been told by a doctor that you have other serious illnesses or disabilities, could you now tell me what they are? (non-cancer illness). | — | [
|
— | European | — | UKB | — |
PSS000247 | ICD-10 defined Primary open-angle glaucoma (POAG) | — | [
|
— | European | — | UKB | — |
PSS000248 | Glaucoma cases were defined as those who (i) had an ICD-10 diagnosis of ‘primary open angle glaucoma’, ‘other glaucoma’ or ‘glaucoma, unspecified’; (ii) responded ‘glaucoma’ to the question ‘Has a doctor told you that you have any of the following problems with your eyes?’; or (iii) responded ‘glaucoma’ to the question ‘In the touch screen you selected that you have been told by a doctor that you have other serious illnesses or disabilities, could you now tell me what they are? (non-cancer illness). | — | [
|
— | European | — | UKB | — |
PSS000249 | Glaucoma cases were defined as those who (i) had an ICD-10 diagnosis of ‘primary open angle glaucoma’, ‘other glaucoma’ or ‘glaucoma, unspecified’; (ii) responded ‘glaucoma’ to the question ‘Has a doctor told you that you have any of the following problems with your eyes?’; or (iii) responded ‘glaucoma’ to the question ‘In the touch screen you selected that you have been told by a doctor that you have other serious illnesses or disabilities, could you now tell me what they are? (non-cancer illness). | — | [
|
— | South Asian | — | UKB | — |
PSS011837 | — | — | 429 individuals | — | European | — | PROGRESSA | — |
PSS011837 | — | — | 5 individuals | — | Asian unspecified | — | PROGRESSA | — |
PSS011837 | — | — | 1 individuals | — | Greater Middle Eastern (Middle Eastern, North African or Persian) | — | PROGRESSA | — |
PSS011837 | — | — | 1 individuals | — | Hispanic or Latin American | — | PROGRESSA | — |
PSS011837 | — | — | 19 individuals | — | Not reported | — | PROGRESSA | — |
PSS011408 | — | — | 903 individuals, 42.7 % Male samples |
— | European | — | ANZRAG | — |